154 related articles for article (PubMed ID: 10630186)
1. Lentiviral gene transfer to the nonhuman primate brain.
Kordower JH; Bloch J; Ma SY; Chu Y; Palfi S; Roitberg BZ; Emborg M; Hantraye P; Déglon N; Aebischer P
Exp Neurol; 1999 Nov; 160(1):1-16. PubMed ID: 10630186
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
4. In situ transduction of stromal cells and thymocytes upon intrathymic injection of lentiviral vectors.
Marodon G; Klatzmann D
BMC Immunol; 2004 Aug; 5():18. PubMed ID: 15318949
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
Mandel RJ; Snyder RO; Leff SE
Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
[TBL] [Abstract][Full Text] [Related]
6. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
7. Expression, bioactivity, and safety 1 year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease.
Herzog CD; Brown L; Gammon D; Kruegel B; Lin R; Wilson A; Bolton A; Printz M; Gasmi M; Bishop KM; Kordower JH; Bartus RT
Neurosurgery; 2009 Apr; 64(4):602-12; discussion 612-3. PubMed ID: 19349823
[TBL] [Abstract][Full Text] [Related]
8. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
[TBL] [Abstract][Full Text] [Related]
9. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
10. Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector.
Maidment NT; Tan AM; Bloom DC; Anton B; Feldman LT; Stevens JG
Exp Neurol; 1996 May; 139(1):107-14. PubMed ID: 8635556
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
13. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
Herzog CD; Dass B; Holden JE; Stansell J; Gasmi M; Tuszynski MH; Bartus RT; Kordower JH
Mov Disord; 2007 Jun; 22(8):1124-32. PubMed ID: 17443702
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
15. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
Kordower JH; Herzog CD; Dass B; Bakay RA; Stansell J; Gasmi M; Bartus RT
Ann Neurol; 2006 Dec; 60(6):706-15. PubMed ID: 17192932
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors.
Ahmed BY; Chakravarthy S; Eggers R; Hermens WT; Zhang JY; Niclou SP; Levelt C; Sablitzky F; Anderson PN; Lieberman AR; Verhaagen J
BMC Neurosci; 2004 Jan; 5():4. PubMed ID: 15005815
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
19. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters.
Hioki H; Kameda H; Nakamura H; Okunomiya T; Ohira K; Nakamura K; Kuroda M; Furuta T; Kaneko T
Gene Ther; 2007 Jun; 14(11):872-82. PubMed ID: 17361216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
